Comparing the effect of fish oil on the occurrence of atrial fibrillation with placebo (olive oil) after coronary artery bypass graft surgery in patients who are undergoing CABG surgery in the rajaei heart center in 2013, a randomized clinical trial

Comparing the effect of fish oil on the occurrence of atrial fibrillation with placebo (olive oil) after coronary artery bypass graft surgery in patients who are undergoing CABG surgery in the rajaei heart center in 2014, a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013070713886N1

Enrollment

392

Registered

2014-08-30

Start date

2014-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post coronary artery bypass graft surgery atrial fibrilation.. Atrial fibrillation and flutter

Interventions

Intervention 1: Intervention group: 1 gr fish oil pearls containing 300mg EPA and 200 mg DHA, twice a day , given the patients at least 5 day before surgery until time of discharge. Intervention 2: Co

Treatment - Drugs

Placebo

Intervention group: 1 gr fish oil pearls containing 300mg EPA and 200 mg DHA, twice a day , given the patients at least 5 day before surgery until time of discharge.

Control group: 1 gr olive oil pearls , twice a day, given to the patients, at least 5 days before surgery until time of discharge.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : All patients over 18 years old who are candidate for CABG surgery. Exclusion criteria: previous diagnosis of AF or atrial flutter; use of anti arrhythmic drugs (class 1&3) over the last 3 months; emergency surgery; MI over the last 2 weeks; emergency reoperation; post operative pacemaker placement; CABG and valve surgery; any conditions that can be effective on the digestion or absorption of food fatty acids; withdrew patients from continuing to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Atrial fibrilation. Timepoint: After coronary artery baypass graft surgery AF. Method of measurement: Checking of patients rhythm in open heart surgery ICU.	—

Secondary

Measure	Time frame
Length of hospitalization. Timepoint: Time of discharge. Method of measurement: Patients records.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAwat Yousefi Azar

Tehan University of Medical Sciences

a.youa@yahoo.com; aya.intensivist@yahoo.com

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026